1. |
Galey-Fontaine J, Cédrin-Durnerin I, Chabi R, et al. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders[J]. Reprod Biomed Online, 2005, 10(1):94-99.
|
2. |
Mohsen IA, El Din RE. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI[J]. Gynecol Endocrinol, 2013, 29(2):105-108.
|
3. |
Lamazou F, Fuchs F, Grynberg M, et al. Cancellation of IVF-ET cycles:poor prognosis, poor responder, or variability of the response to controlled ovarian hyperstimualtion? An analysis of 142 cancellations[J]. J Gynecol Obstet Biol Reprod (Paris), 2012, 41(1):41-47.
|
4. |
La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)[J]. Hum Reprod Update, 2010, 16(2):113-130.
|
5. |
田莉, 吴丹, 沈浣. 长、短效GnRH激动剂在控制性超排卵长方案中应用效果比较[J]. 中国妇产科临床杂志, 2009, 10(6):413-415, 453.
|
6. |
郭慧, 罗克丽, 龚斐, 等. 三种不同促排卵方案在卵巢低反应患者中的应用[J]. 医学临床研究, 2011, 28(5):873-875.
|
7. |
匡延平. 微刺激促排卵方案的临床研究[J]. 生殖医学杂志, 2010, 19(4):356-359.
|
8. |
Polinder S, Heijnen EM, Macklon NS, et al. Cost-effectiveness of a mild compared with a standard strategy for IVF:a randomized comparison using cumulative term live birth as the primary endpoint[J]. Hum Reprod, 2008, 23(2):316-323.
|
9. |
Revelli A, Casano S, Salvagno F, et al. Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization[J]. Reprod Biol Endocrinol, 2011, 9:25.
|